Paul Phull joins PharmaVentures
pharmafile | August 31, 2010 | Appointment | Sales and Marketing |Â Â PharmaVentures, appointment, sales and marketingÂ
Oxford, UK-based PharmaVentures has appointed Paul Phull as a senior director to its corporate advisory business.
He joins the company from UK specialty pharma company Sinclair Pharma, where he was responsible for the development of the international business with a marketing partner network spanning over 80 countries.
He has more than 24 years of senior level experience in the pharmaceutical, biotechnology and medical device industries, and in his new role will be responsible for developing PharmaVentures’ corporate advisory business.
“I am very pleased to welcome Paul to PharmaVentures,” said chief executive Dr Fintan Walton. “His strategic approach and industry experience will significantly enhance corporate advisory services, particularly with respect to our transactions offerings.”
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






